Electroencephalography in Primary Progressive Aphasia and Apraxia of Speech.

Electroencephalography (EEG) Frontotemporal dementia Primary Progressive Aphasia Primary Progressive Apraxia of Speech

Journal

Aphasiology
ISSN: 0268-7038
Titre abrégé: Aphasiology
Pays: England
ID NLM: 8708531

Informations de publication

Date de publication:
2019
Historique:
entrez: 20 11 2019
pubmed: 20 11 2019
medline: 20 11 2019
Statut: ppublish

Résumé

Past research has demonstrated that electroencephalography (EEG) is sensitive to what we now know as Primary Progressive Aphasia (PPA); however, the EEG profiles of patients with Primary Progressive Apraxia of Speech (PPAOS) and PPA, in the context of current consensus criteria, have not been studied. The primary goal of this study was to explore the EEG profiles of patients of the nonfluent/ agrammatic variant of PPA (agPPA) and PPAOS. Three patients with agPPA and five patients with PPAOS (two with aphasia) completed a head MRI scan and clinical EEG recording. Clinical radiologists and electrophysiologists reviewed respective imaging, blinded to clinical diagnosis. Patients with PPAOS who did not have aphasia had normal EEGs, while those with aphasia demonstrated theta slowing. Patients with agPPA also showed theta slowing, with one exception. MRI scans showed non-specific, age-related changes across clinical presentations. This preliminary study suggests theta slowing is consistent with neurodegenerative aphasia, but not isolated apraxia of speech. EEG is a low-cost mechanism to identify possible biomarkers for use when clinical severity limits behavioral examinations or expert examiners are unavailable.

Sections du résumé

BACKGROUND BACKGROUND
Past research has demonstrated that electroencephalography (EEG) is sensitive to what we now know as Primary Progressive Aphasia (PPA); however, the EEG profiles of patients with Primary Progressive Apraxia of Speech (PPAOS) and PPA, in the context of current consensus criteria, have not been studied.
AIMS OBJECTIVE
The primary goal of this study was to explore the EEG profiles of patients of the nonfluent/ agrammatic variant of PPA (agPPA) and PPAOS.
METHODS AND PROCEDURES METHODS
Three patients with agPPA and five patients with PPAOS (two with aphasia) completed a head MRI scan and clinical EEG recording. Clinical radiologists and electrophysiologists reviewed respective imaging, blinded to clinical diagnosis.
OUTCOMES AND RESULTS RESULTS
Patients with PPAOS who did not have aphasia had normal EEGs, while those with aphasia demonstrated theta slowing. Patients with agPPA also showed theta slowing, with one exception. MRI scans showed non-specific, age-related changes across clinical presentations.
CONCLUSIONS CONCLUSIONS
This preliminary study suggests theta slowing is consistent with neurodegenerative aphasia, but not isolated apraxia of speech. EEG is a low-cost mechanism to identify possible biomarkers for use when clinical severity limits behavioral examinations or expert examiners are unavailable.

Identifiants

pubmed: 31741547
doi: 10.1080/02687038.2018.1545991
pmc: PMC6860920
mid: NIHMS1520224
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1410-1417

Subventions

Organisme : NIDCD NIH HHS
ID : L30 DC014830
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC012519
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC014942
Pays : United States

Références

Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
J Neurol Neurosurg Psychiatry. 1999 Mar;66(3):401-3
pubmed: 10084544
Neurology. 1996 Jul;47(1):1-9
pubmed: 8710059
Cortex. 2018 Feb;99:358-374
pubmed: 29353121
Nat Rev Neurol. 2010 Feb;6(2):88-97
pubmed: 20139998
Brain. 1962 Dec;85:665-78
pubmed: 14026018
J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):67-71
pubmed: 20935323
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
Ann Neurol. 2001 Apr;49(4):425-32
pubmed: 11310619
Arch Clin Neuropsychol. 1999 Aug;14(6):481-7
pubmed: 14590575
Neurology. 2013 Jan 29;80(5):496-503
pubmed: 23359374
Brain. 2014 Apr;137(Pt 4):1176-92
pubmed: 24574501
Lancet Neurol. 2014 Jun;13(6):614-29
pubmed: 24849862
Mov Disord. 2008 Nov 15;23(15):2129-70
pubmed: 19025984
Neurology. 2011 Mar 15;76(11):1006-14
pubmed: 21325651
Brain. 2006 Jun;129(Pt 6):1385-98
pubmed: 16613895
Ann Neurol. 2003;54 Suppl 5:S15-9
pubmed: 12833363
Cortex. 2015 Aug;69:220-36
pubmed: 26103600
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Neurology. 1984 Jul;34(7):939-44
pubmed: 6610841
Ann Neurol. 1982 Jun;11(6):592-8
pubmed: 7114808
Am J Alzheimers Dis Other Demen. 2009 Oct-Nov;24(5):408-16
pubmed: 19700669
Clin Neurophysiol. 2006 Oct;117(10):2236-42
pubmed: 16920021
Parkinsonism Relat Disord. 2007 Aug;13(6):348-54
pubmed: 17347022
Brain. 2012 May;135(Pt 5):1522-36
pubmed: 22382356
Brain Lang. 2018 Sep;184:54-65
pubmed: 29980072
J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1352-5
pubmed: 15314134
Eur J Neurol. 2018 Nov;25(11):1352-1357
pubmed: 29935044

Auteurs

Rene L Utianski (RL)

Department of Neurology, Mayo Clinic, Rochester, MN.

John N Caviness (JN)

Department of Neurology, Mayo Clinic, Phoenix, AZ.

Gregory A Worrell (GA)

Department of Neurology, Mayo Clinic, Rochester, MN.

Joseph R Duffy (JR)

Department of Neurology, Mayo Clinic, Rochester, MN.

Heather M Clark (HM)

Department of Neurology, Mayo Clinic, Rochester, MN.

Mary M Machulda (MM)

Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN.

Jennifer L Whitwell (JL)

Department of Radiology, Mayo Clinic, Rochester, MN.

Keith A Josephs (KA)

Department of Neurology, Mayo Clinic, Rochester, MN.

Classifications MeSH